Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)

NCT06121830 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-erosive Reflux Disease
Non-Erosive Gastro-Esophageal Reflux Disease
Non-Erosive Esophageal Reflux Disease

Interventions

DRUG: DWP14012 20mg
DRUG: DWP14012 40mg
DRUG: Placebo

Sponsor

Daewoong Pharmaceutical Co. LTD.